7 Dividend-Paying Large-Cap Stocks to Buy in May

In This Article:

The article covers three dividend-paying large-cap stocks to buy this month

  • Pfizer (NYSE:PFE): Massive growth runway for its coronavirus vaccine and pill after two blockbuster years

  • Vornado Realty Trust (NYSE:VNO): Office occupancy rates are rising, leading to robust profits

  • International Business Machines (NYSE:IBM): Hybrid cloud offers incredible upside potential

  • Simon Property Group (NYSE:SPG): Cash flow generating machine with a stellar profitability profile

  • Kinder Morgan (NYSE:KMI): Committed towards expanding shareholder rewards

  • Altria (NYSE:MO): Stable business with healthy profitability

  • Lumen Technologies (NYSE:LUMN): Enticing quantum fiber business, which could be a huge money-spinner down the line

7 Safe Dividend Stocks for Investors to Buy Right Now
7 Safe Dividend Stocks for Investors to Buy Right Now


Click to Enlarge

Source: Shutterstock

The equity market has taken a hammering amidst multiple debilitating headwinds. The result is a “risk-off” environment, where fixed-income investments have become highly attractive for investors. For instance, 10-year Treasury bonds are paying roughly a 2.8% yield, almost double the yield from last summer.

Nevertheless, investing in dividend-paying large-cap stocks offering healthy dividend yields could be a savvy strategy at this time. Moreover, many of these stocks have pulled back considerably and are now trading at beaten-down valuations.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Dividend stocks make regular distributions to stockholders and can be a useful source of stable income. The best dividend stocks may offer a way for investors to increase their wealth over the long term rapidly.

However, some reliable dividend stocks are struggling, so it’s best to be careful while stock-picking in today’s volatile environment.

PFE

Pfizer

48.01

VNO

Vornado Realty Trust

$36.86

IBM

International Business Machines

$135.41

SPG

Simon Property Group

$121.58

KMI

Kinder Morgan

$18.71

MO

Altria

$55.88

LUMN

Lumen Technologies

$10.63

Pfizer (PFE)

Pfizer (PFE) logo on Pfizer building. Pfizer is an American pharmaceutical corporation.
Pfizer (PFE) logo on Pfizer building. Pfizer is an American pharmaceutical corporation.

Source: Manuel Esteban / Shutterstock.com

Pfizer (NYSE:PFE) is one of the leading pharmaceutical companies which have been at the forefront in battling the coronavirus pandemic. Cominarty, its Covid-19 vaccine developed in conjunction with BioNTech (NASDAQ:BNTX), helped bump revenues by 94% last year. Moreover, the company’s net income improved by an incredible 128.6% in 2021.

After a strong performance in the stock market in the past couple of years, PFE stock has been struggling of late. Investors feel that its Comirnaty sales have peaked, resulting in significantly lower revenues in 2022. However, Pfizer is already guiding for a whopping $26 billion in Comirnaty sales this year, and its Covid-19 pill Paxlovid could be the cherry on top.